Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

A woman's male-like physical changes were caused by two rare ovarian conditions.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.